Biomarkers in Infection

Recruiting Observational Study
Sepsis Infection Inflammation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
4,200 (estimated)
Sponsor
Beth Israel Deaconess Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for Infected subjects: * Age 18 years of age or older * Confirmed or suspected infection Inclusion Criteria for Control Subjects: * Age 18 years of age or older * A non-infectious clinical presentation to include * Normal white blood cell count ( \> 4,000 and/or \< 12,000) * No…
Contacts

Nathan Shapiro, MD MPH

617-754-2343

nshapiro@bidmc.harvard.edu

CONTACT

Carlo Ottanelli, BSc

617-650-0042

cottanel@bidmc.harvard.edu

CONTACT